Publication | Closed Access

Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study

MedicineBiliary CancerPathologyMultiple Basket StudyPhase 2ACancer TreatmentOncologyCancer ResearchRadiology